These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23051697)

  • 61. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
    Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W
    Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A cost analysis of screening methodology for family members of colorectal cancer patients.
    Rozen P; Ron E
    Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.
    Longstreth GF; Anderson DS; Zisook DS; Shi JM; Lin JC
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2929-2936.e1. PubMed ID: 32007541
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
    Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
    Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colorectal cancer screening: results of a 5-year program in asymptomatic subjects at increased risk.
    Pezzoli A; Matarese V; Rubini M; Simoni M; Caravelli GC; Stockbrugger R; Cifalà V; Boccia S; Feo C; Simone L; Trevisani L; Liboni A; Gullini S
    Dig Liver Dis; 2007 Jan; 39(1):33-9. PubMed ID: 17049323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.
    Regula J; Rupinski M; Kraszewska E; Polkowski M; Pachlewski J; Orlowska J; Nowacki MP; Butruk E
    N Engl J Med; 2006 Nov; 355(18):1863-72. PubMed ID: 17079760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Familial risk of colorectal cancer in subjects attending an organised screening programme.
    Castiglione G; Visioli CB; Zappa M; Grazzini G; Mallardi B; Mantellini P
    Dig Liver Dis; 2012 Jan; 44(1):80-3. PubMed ID: 21925983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
    Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
    Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surveillance behavior of women with a reported family history of colorectal cancer.
    Clavel-Chapelon F; Joseph R; Goulard H
    Prev Med; 1999 Feb; 28(2):174-8. PubMed ID: 10048109
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.
    Kim NH; Kwon MJ; Kim HY; Lee T; Jeong SH; Park DI; Choi K; Jung YS
    Dig Liver Dis; 2016 Jun; 48(6):667-72. PubMed ID: 27012445
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
    Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
    Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.